ELISA News and Research

RSS

Novel antibody that targets the N-terminal domain of SARS-CoV-2 identified

A new study discusses the targeted discovery of NTD-reactive antibodies from an individual who had recovered from SARS-CoV-2 infection.

19 Jan 2022

SARS-CoV-2 vaccination of convalescents suggested to boost neutralization capacity against variants

A new study assessed the neutralization capacity of sera from convalescents—some even vaccinated—against the Wuhan (D614G), Delta and Omicron variants of SARS-CoV-2.

19 Jan 2022

Emerging nanomaterials-based biosensor for detecting SARS-CoV-2

A new study aimed to highlight the different smart and emerging nanomaterials used to detect SARS-CoV-2.

19 Jan 2022

SARS-CoV-2 protein biosensor employing colloidal quantum dots-modified electrode

An all-solid-state SARS-CoV-2 protein biosensor using lead sulfide colloidal quantum dots--modified electrode is demonstrated in this study by a group of researchers from several institutions.

18 Jan 2022

Applications of bioconjugated nanomaterials in SARS-CoV-2 diagnostics

In this study, the researchers not only elucidate the recent bioconjugated nanomaterials for targeted diagnosis of SARS-CoV-2, but they also provide the rationale behind these developments by discussing the mechanisms and approaches.

18 Jan 2022

Comparison of antibody responses and vaccine effectiveness in healthcare workers post-primary COVID-19 vaccination

The authors highlight that they have shown that boosted individuals are significantly more protected against SARS-CoV-2 infection than any other group

18 Jan 2022

SARS-CoV-2 interacts with heparan sulfate to activate the alternative pathway

A new study discusses the activation of the complement system to determine its role in COVID-19-related deaths.

17 Jan 2022

Seroepidemiologic surveys for assessment of the COVID-19 pandemic in Japan

In a new study, a team of researchers demonstrated that Japan had witnessed a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant-induced endemic between August and December 2021.

17 Jan 2022

Monitoring rodents for SARS-CoV-2 and other coronaviruses, Hong Kong

A new study published in the Centers for Disease Control and Prevention’s Emerging Infectious Diseases journal has hypothesized that locations with positive SARS-CoV-2 in sewage could be used as potential surveillance targets to analyze if pestiferous urban rodents shed SARS-CoV-2 into the environment.

16 Jan 2022

Study shows possible reverse zoonoses of SARS-CoV-2 from humans to animals

A new study describes an instance of natural infection of SARS-CoV-2 in a puma during the first wave and three lions during the third wave in a private zoo in South Africa in at least three transmission events from their handlers.

14 Jan 2022

Specific immunoresponse to SARS-CoV-2 in cats and dogs housed with COVID-19 patients

Researchers conducted a detailed epitope mapping of Np and developed an experimental double antigen-based ELISA.

13 Jan 2022

Study confirms waning immunity in adolescents following two doses of mRNA COVID-19 vaccines

Researchers test the durability of antibodies produced by a vaccine-induced full-length SARS-CoV-2 spike protein and receptor-binding domain.

13 Jan 2022

Exploring the structural basis of antibody evasion and enhanced transmission of the SARS-CoV-2 Omicron variant

In a new study, researchers used cryogenic electron microscopy (cryo-EM) analysis to capture the open and closed states of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant’s spike protein.

13 Jan 2022

COVID-19 infection sera analysis against varying antigens of SARS-CoV-2 variants

In a new study, researchers assessed the sera from COVID-19 infected and vaccinated individuals against the receptor-binding domain in the spike protein of the SARS-CoV-2 wildtype virus and its variants.

13 Jan 2022

The impact of Comirnaty vaccination on the levels of PEG specific antibodies

Researchers observe an increase in PEG antibodies following vaccination with the SARS-CoV-2 mRNA lipid nanoparticle vaccine.

12 Jan 2022

An egg-derived SARS-CoV-2 vaccine and treatment for COVID-19 disease

A new study, posted to the medRxiv* preprint server, has focussed on the development of intranasal prophylaxis against SARS-CoV-2 infection.

11 Jan 2022

Neutralization of SARS-CoV-2 variants by three-dose mRNA vaccinated kidney transplant recipient sera

In a new study, researchers determined three-dose messenger ribonucleic acid (mRNA) vaccinated kidney transplant recipients’ (KTRs) neutralizing responses against SARS-COV-2 variants, breakthrough coronavirus disease 2019 infection rate, and transplant rejection rate.

10 Jan 2022

ELISA News and Research

Novel antibody that targets the N-terminal domain of SARS-CoV-2 identified

SARS-CoV-2 vaccination of convalescents suggested to boost neutralization capacity against variants

Emerging nanomaterials-based biosensor for detecting SARS-CoV-2

SARS-CoV-2 protein biosensor employing colloidal quantum dots-modified electrode

Applications of bioconjugated nanomaterials in SARS-CoV-2 diagnostics

Comparison of antibody responses and vaccine effectiveness in healthcare workers post-primary COVID-19 vaccination

SARS-CoV-2 interacts with heparan sulfate to activate the alternative pathway

Seroepidemiologic surveys for assessment of the COVID-19 pandemic in Japan

Monitoring rodents for SARS-CoV-2 and other coronaviruses, Hong Kong

Study shows possible reverse zoonoses of SARS-CoV-2 from humans to animals

Specific immunoresponse to SARS-CoV-2 in cats and dogs housed with COVID-19 patients

Study confirms waning immunity in adolescents following two doses of mRNA COVID-19 vaccines

Exploring the structural basis of antibody evasion and enhanced transmission of the SARS-CoV-2 Omicron variant

COVID-19 infection sera analysis against varying antigens of SARS-CoV-2 variants

The impact of Comirnaty vaccination on the levels of PEG specific antibodies

An egg-derived SARS-CoV-2 vaccine and treatment for COVID-19 disease

Neutralization of SARS-CoV-2 variants by three-dose mRNA vaccinated kidney transplant recipient sera

Humoral and cellular response to primary and booster COVID-19 vaccination in immunosuppressed patients

Reinfection with SARS-CoV-2 in children

Study suggests that previous COVID-19 infections do not affect pregnancy

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News